Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States
CompletedOBSERVATIONAL
Enrollment
127,690
Participants
Timeline
Start Date
February 15, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Conditions
Diabetes Mellitus, Type 2
All Listed Sponsors
lead
Janssen Research & Development, LLC
INDUSTRY
NCT02857764 - Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States | Biotech Hunter | Biotech Hunter